These advances in the functional analyses of the CD47-SIRPα signaling pathway and their novel role in STAT3 activation and tolerance induction in various normal and pathological cellular microenvironments may now provide exciting hints for new therapeutic targets based on manipulating this signaling pathway in autoimmune diseases. This evidence concerns the gene STAT3 and autoimmune disease.